1. Home
  2. AGCO vs NUVL Comparison

AGCO vs NUVL Comparison

Compare AGCO & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGCO Corporation

AGCO

AGCO Corporation

HOLD

Current Price

$104.31

Market Cap

7.8B

Sector

Industrials

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$101.45

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGCO
NUVL
Founded
1990
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
7.1B
IPO Year
1992
2021

Fundamental Metrics

Financial Performance
Metric
AGCO
NUVL
Price
$104.31
$101.45
Analyst Decision
Hold
Strong Buy
Analyst Count
10
15
Target Price
$112.00
$135.00
AVG Volume (30 Days)
737.2K
481.3K
Earning Date
02-05-2026
10-30-2025
Dividend Yield
3.51%
N/A
EPS Growth
121.88
N/A
EPS
5.02
N/A
Revenue
$10,049,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.01
N/A
P/E Ratio
$20.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$73.79
$55.54
52 Week High
$121.16
$112.88

Technical Indicators

Market Signals
Indicator
AGCO
NUVL
Relative Strength Index (RSI) 43.95 45.84
Support Level $103.90 $99.38
Resistance Level $106.03 $106.65
Average True Range (ATR) 2.37 2.78
MACD -0.27 -0.75
Stochastic Oscillator 23.00 24.04

Price Performance

Historical Comparison
AGCO
NUVL

About AGCO AGCO Corporation

Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: